Calidi Biotherapeutics, Inc. (CLDI) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $3.76M | +145.0% |
| 2024 | $1.53M | +118.6% |
| 2023 | -$8.23M | +83.7% |
| 2022 | -$50.44M | -59.6% |
| 2021 | -$31.61M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $3.76M | +145.0% |
| 2024 | $1.53M | +118.6% |
| 2023 | -$8.23M | +83.7% |
| 2022 | -$50.44M | -59.6% |
| 2021 | -$31.61M | — |